- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
John C. Richter
Insights 27 results
Client Alert
May 16, 2022
Cooperation Credit and Attorney-Client Privilege: The Implications of Coburn
Article
October 27, 2021
Congress Can Do Better Against Fraud
Article · Source: U.S. Chamber of Commerce Litigation Center Blog
August 12, 2021
Top False Claims Act Developments
Feature
February 10, 2021
General Counsel Internal Investigations Decision Tree for the Automotive Industry
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Energy Industry
Feature
January 15, 2021
General Counsel’s Decision Tree
Feature
January 15, 2021
General Counsel Internal Investigations Decision Tree for the Life Sciences Industry
Article · Source: Law360
August 21, 2020
Pandemic Is No Excuse To Limit Defendants' Trial Rights
Article · Source: Law360
March 3, 2020
Foreign Influence Lessons From Research Org FCA Deal
Client Alert
February 25, 2020
DOJ Announces FCA Settlement with NIH-Funded Institute Related to Disclosure of Foreign Influence in Research
Client Alert
October 16, 2019
DOJ Issues Guidance for Evaluating a Business Organization's Inability to Pay a Criminal Fine or Penalty
Client Alert
September 24, 2018
Echoes of the Brand Memo